Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 980149741000036111 | ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet, 150 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 980149751000036114 | ascorbic acid 250 mg + cupric oxide 1.25 mg + D-alpha-tocopheryl acid succinate 165 mg + zinc (as oxide) 40 mg tablet, 150 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet, 150 | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet, 150 | has MPUU | ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Macu-Vision tablet: film-coated, 150 | Is a | False | ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet, 150 | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR